Baxter debuts new app for patients with CKD at ASN Kidney Week
Click Here to Manage Email Alerts
Baxter International Inc. and Ayogo have released CKD&Me, an app for smartphones and tablets that tailors its educational content to the individual learning needs of patients with chronic kidney disease.
Baxter is piloting the app in several nephrology practices across the country and is offering demonstrations in their booth (#1527) during ASN Kidney Week.
CKD&Me supplements the education programs provided by nephrologists and their teams, Baxter said in a press release. The digital tool “provides objective pre-dialysis education to help patients feel empowered to confidently engage in their kidney care and participate in shared decision-making about their therapy,” according to the company release. “It also provides nephrologists insights into patients’ level of engagement in the education process, their values, lifestyle needs and confidence in therapy selection.”
Research suggests more comprehensive pre-dialysis education better engages patients in taking an active role and improving their outcomes, and that customized interactions are shown to be significantly more effective than static programs, Baxter said.
“Our shared goal is to provide patients with tools that are timely, contextually relevant and personally tailored,” Michael Fergusson, CEO of Ayogo, said in the release. “By meeting patients where they are, by building an understanding of their goals and values, and monitoring the psychosocial factors that influence treatment success, we can provide patients with support that effectively adapts to their individual needs and circumstances.” CKD&Me is expected to fully launch around mid-2020, Baxter said.
ASN Kidney Week attendees can also get information at the Baxter booth on a new mobile ordering system, which is designed to simplify patients’ home dialysis ordering experience from their smartphones, tablets and computers and learn about a new Baxter-led peritoneal dialysis nurse training program, set to go live in the second quarter of 2020.
Reference: